Studies related to Sedation and Valeriana officinalis

Extract Of Valerian Root (Valeriana Officinalis L.) Vs. Placebo In Treatment Of Obsessive-compulsive Disorder: A Randomized Double-blind Study

Effect Increase
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 31
Sex Both Genders
Age Range 18-29, 30-44
Notes for this study:
Supplementation of 750mg valerian root daily for eight weeks in persons with diagnosed OCD was able to reduce symptoms on the Y-BOCS by up to 25% (from around 40 points at baseline to 30 points) whereas placebo was half as effective, with a statistically significant difference at week four extending to the end of the study. Treatment was well tolerated aside from somnolence, which was significantly more present as a side-effect in the valerian group.

Full details on all 2 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.